Roivant Sciences Return on Equity (ROE) Growth & History (ROIV)

Roivant Sciences's return on equity was −6.51% for fiscal 2025.

View full Roivant Sciences company overview

Roivant Sciences annual return on equity history

Roivant Sciences annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20252026-03-31−6.51%−3.28 pp
20242025-03-31−3.23%−125.28 pp
20232024-03-31122.05%+193.75 pp
20222023-03-31−71.70%−22.76 pp
20212022-03-31−48.93%

Roivant Sciences return on equity trends

Between the periods ended 2022-03-31 and 2026-03-31, Roivant Sciences's return on equity increased from −48.93% to −6.51%, a change of +42.43 percentage points. The latest reported quarter, Q1 2026, shows −4.33%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Roivant Sciences source filings ↗

Community posts

It’s quiet here.

No posts about ROIV yet. Start the conversation.

Write the first post